Details for New Drug Application (NDA): 091211
NDA 091211 describes ATOVAQUONE AND PROGUANIL HYDROCHLORIDE, which is a drug marketed by Glenmark Pharms Ltd and Mylan and is included in two NDAs. It is available from seven suppliers. Additional details are available on the ATOVAQUONE AND PROGUANIL HYDROCHLORIDE profile page.
The generic ingredient in ATOVAQUONE AND PROGUANIL HYDROCHLORIDE is atovaquone; proguanil hydrochloride. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the atovaquone; proguanil hydrochloride profile page.
The generic ingredient in ATOVAQUONE AND PROGUANIL HYDROCHLORIDE is atovaquone; proguanil hydrochloride. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the atovaquone; proguanil hydrochloride profile page.
Summary for 091211
| Tradename: | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE |
| Applicant: | Glenmark Pharms Ltd |
| Ingredient: | atovaquone; proguanil hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 091211
| Mechanism of Action | Dihydrofolate Reductase Inhibitors |
Suppliers and Packaging for NDA: 091211
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | atovaquone; proguanil hydrochloride | TABLET;ORAL | 091211 | ANDA | A-S Medication Solutions | 50090-1302 | 50090-1302-0 | 7 TABLET, FILM COATED in 1 BOTTLE (50090-1302-0) |
| ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | atovaquone; proguanil hydrochloride | TABLET;ORAL | 091211 | ANDA | A-S Medication Solutions | 50090-1302 | 50090-1302-1 | 12 TABLET, FILM COATED in 1 BOTTLE (50090-1302-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG;100MG | ||||
| Approval Date: | Jan 12, 2011 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 62.5MG;25MG | ||||
| Approval Date: | Apr 6, 2015 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
